Monoclonal antibody
Sponsors
Hoffmann-La Roche, Light Chain Bioscience - Novimmune SA, Assistance Publique Hopitaux De Marseille, Pregistry, Sung-Soo Park
Conditions
Burkitt LymphomaCancerCovid19Diffuse Large B Cell Lymphoma RelapsedGlioblastomaHLA-A*02:01-positiveHealthy VolunteersHigh Grade B-cell Lymphoma
Phase 1
A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas
CompletedNCT00711191
Start: 2008-06-30End: 2011-01-31Updated: 2013-12-24
First in Human Study of an Anti-Toll-like Receptor 4 (TLR4) Monoclonal Antibody (NI-0101) in Adult Healthy Volunteers
CompletedNCT01808469
Start: 2012-11-30End: 2014-03-31Target: 80Updated: 2014-10-24
Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma
NCT03631836
Start: 2019-01-01End: 2022-01-01Target: 34Updated: 2018-08-17
Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers
RecruitingNCT06840119
Start: 2024-01-10End: 2027-11-30Target: 600Updated: 2026-01-28
Unknown Phase
COVID-19 International Drug Pregnancy Registry
RecruitingNCT05013632
Start: 2021-12-01End: 2027-09-30Target: 2000Updated: 2025-09-26
Immunotherapy in Lymphoma
RecruitingNCT06796517
Start: 2024-06-26End: 2025-12-31Target: 72Updated: 2025-01-28
Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development
RecruitingNCT07033663
Start: 2018-06-01End: 2028-05-01Target: 90Updated: 2025-08-15
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
RecruitingNCT07051850
Start: 2025-07-14End: 2025-12-31Target: 174Updated: 2025-07-15